Different metabolic patterns analysis of Parkinsonism on the 18F-FDG PET.

Idiopathic Parkinson's disease (IPD), progressive supranuclear palsy (PSP) and multiple system atrophy (MSA) are the most common movement disorders associated with neurodegenerative disease. A clinical differential diagnosis of IPD and atypical Parkinsonian disorders, such as MSA and PSP, is often complicated by the presence of symptoms common to both groups. Since Parkinsonism has a different pathophysiology in the cortical and subcortical brain structures, assessing the regional cerebral glucose metabolism may assist in making a differential diagnosis of Parkinsonism. The 18F-FDG PET images of IPD, MSA and PSP were assessed using statistical parametric mapping (SPM) in order to determine the useful metabolic patterns. Twenty-four patients with Parkinsonism: eight patients (mean age 67.9 +/- 10.7 years; M/F: 3/5) with IPD, nine patients (57.9 +/- 9.2 years; M/F: 4/5) with MSA and seven patients (67.6 +/- 4.8 years; M/F: 3/4) with PSP were enrolled in this study. All patients with Parkinsonism and 22 age-matched normal controls underwent 18F-FDG PET, (after 370 MBq 18F-FDG). The three groups and the individual IPD, MSA and PSP patients were compared with a normal control group using a two-sided t-test of SPM (uncorrected P < 0.01, extent threshold > 100 voxel). The IPD, MSA and PSP groups showed significant hypometabolism in the cerebral neocortex compared to the normal control group. The MSA group showed significant hypometabolism in the putamen, pons and cerebellum compared to the normal controls and IPD groups. In addition, PSP showed significant hypometabolism in the caudate nucleus, the thalamus, midbrain and the cingulate gyrus compared to the normal controls, the IPD and the MSA groups. In conclusion, an assessment of the 18F-FDG PET images using SPM may be a useful adjunct to a clinical examination when making a differential diagnosis of Parkinsonism.

[1]  W. Heiss,et al.  Differentiating multiple system atrophy from Parkinson’s disease: contribution of striatal and midbrain MRI volumetry and multi-tracer PET imaging , 2002, Journal of neurology, neurosurgery, and psychiatry.

[2]  T. Vogl,et al.  Relative quantification of signal on T2-weighted images in the basal ganglia: limited value in differential diagnosis of patients with parkinsonism , 1999, Neuroradiology.

[3]  Shozo Tobimatsu,et al.  Cerebral metabolic changes in early multiple system atrophy: a PET study , 2002, Journal of the Neurological Sciences.

[4]  Masanori Ichise,et al.  Combination of dopamine transporter and D2 receptor SPECT in the diagnostic evaluation of PD, MSA, and PSP , 2002, Movement disorders : official journal of the Movement Disorder Society.

[5]  D. J. Brooks,et al.  Morphological and functional imaging studies on the diagnosis and progression of Parkinson’s disease , 2000, Journal of Neurology.

[6]  Karl J. Friston,et al.  Commentary and Opinion: II. Statistical Parametric Mapping: Ontology and Current Issues , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[7]  R P Maguire,et al.  Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease. , 1997, Brain : a journal of neurology.

[8]  T. Yen,et al.  Differential diagnosis of Parkinson's disease and vascular parkinsonism by (99m)Tc-TRODAT-1. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  E. Broussolle,et al.  Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson’s disease , 2001, Neurophysiologie Clinique/Clinical Neurophysiology.

[10]  F. Tison,et al.  Routine MRI for the differential diagnosis of Parkinson's disease, MSA, PSP, and CBD , 2003, Journal of Neural Transmission.

[11]  P. David Mozley,et al.  Logistic discriminant parametric mapping: a novel method for the pixel-based differential diagnosis of Parkinson’s disease , 1999, European Journal of Nuclear Medicine.

[12]  K. Van Laere,et al.  Anatomically standardised 99mTc-ECD brain perfusion SPET allows accurate differentiation between healthy volunteers, multiple system atrophy and idiopathic Parkinson's disease , 2002, European Journal of Nuclear Medicine and Molecular Imaging.

[13]  C. Good,et al.  Differentiation of atypical parkinsonian syndromes with routine MRI , 2000, Neurology.

[14]  N. Hashimoto,et al.  Magnetic resonance imaging distinguishes progressive supranuclear palsy from multiple system atrophy , 2000, Journal of Neural Transmission.

[15]  D J Brooks,et al.  Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data. , 1994, Journal of neurology, neurosurgery, and psychiatry.

[16]  Y Ben-Shlomo,et al.  Prevalence of progressive supranuclear palsy and multiple system atrophy: a cross-sectional study , 1999, The Lancet.

[17]  Robert B. Innis,et al.  [123I]β‐CIT SPECT imaging demonstrates reduced density of striatal dopamine transporters in Parkinson's disease and multiple system atrophy , 2001 .

[18]  Karl J. Friston,et al.  Voxel-Based Morphometry—The Methods , 2000, NeuroImage.

[19]  J R Moeller,et al.  Early differential diagnosis of Parkinson's disease with 18F‐fluorodeoxyglucose and positron emission tomography , 1995, Neurology.

[20]  M. Skalej,et al.  Magnetic resonance imaging–based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy , 1999, Annals of neurology.

[21]  C. Counsell,et al.  Clinical usefulness of MRI in multisystem atrophy , 1999, Journal of neurology, neurosurgery, and psychiatry.

[22]  A. Bol,et al.  Decreased glucose utilization in the striatum and frontal lobe in probable striatonigral degeneration , 1989, Annals of neurology.

[23]  W. Poewe,et al.  The differential diagnosis of Parkinson's disease. , 2002, European journal of neurology.

[24]  Tetsuya Mori,et al.  Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration , 2002, Journal of the Neurological Sciences.

[25]  Angelo Antonini,et al.  Tc‐99m ethylene cysteinate dimer SPECT in the differential diagnosis of parkinsonism , 2002, Movement disorders : official journal of the Movement Disorder Society.

[26]  Karl J. Friston,et al.  Statistical parametric mapping with 18F-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson’s disease , 1999, Journal of neurology, neurosurgery, and psychiatry.